Search research articles
Contact Us
Filters
Showing results (1-10 of 454) with videos related to
Page
of 46
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
April 24, 2014
Vemurafenib
Claus Garbe, Sail Abusaif, Thomas K Eigentler
Melanoma Research
|
August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma
Sail Abusaif, Zeinab Jradi, Laura Held, et al.
Melanoma Research
|
May 15, 2007
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
Claus Garbe, Thomas K Eigentler
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Vemurafenib
Claus Garbe, Thomas K Eigentler
Expert Opinion on Pharmacotherapy
|
September 3, 2013
Protein kinase inhibitors in melanoma
Thomas K Eigentler, Friedegund Meier, Claus Garbe
The Lancet. Oncology
|
December 10, 2003
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
Thomas K Eigentler, Ulrich M Caroli, Peter Radny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2004
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society
Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry
Thomas K Eigentler, Petra G Buettner, Ulrike Leiter, et al.
Cancer
|
January 5, 2005
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society
Petra G Buettner, Ulrike Leiter, Thomas K Eigentler, et al.
British Journal of Cancer
|
June 29, 2018
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
Nikolaus B Wagner, Andrea Forschner, Ulrike Leiter, et al.
Page
of 46
Search research articles
Search
Showing results (1-10 of 454) with videos related to
Sort By:
Page
of 46
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
April 24, 2014
Vemurafenib
Claus Garbe, Sail Abusaif, Thomas K Eigentler
Melanoma Research
|
August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma
Sail Abusaif, Zeinab Jradi, Laura Held, et al.
Melanoma Research
|
May 15, 2007
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
Claus Garbe, Thomas K Eigentler
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Vemurafenib
Claus Garbe, Thomas K Eigentler
Expert Opinion on Pharmacotherapy
|
September 3, 2013
Protein kinase inhibitors in melanoma
Thomas K Eigentler, Friedegund Meier, Claus Garbe
The Lancet. Oncology
|
December 10, 2003
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
Thomas K Eigentler, Ulrich M Caroli, Peter Radny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2004
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society
Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry
Thomas K Eigentler, Petra G Buettner, Ulrike Leiter, et al.
Cancer
|
January 5, 2005
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society
Petra G Buettner, Ulrike Leiter, Thomas K Eigentler, et al.
British Journal of Cancer
|
June 29, 2018
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
Nikolaus B Wagner, Andrea Forschner, Ulrike Leiter, et al.
Page
of 46